健帆生物: 关于健帆转债恢复转股的提示性公告

Group 1 - The company issued 10 million convertible bonds with a total amount of RMB 1 billion, which can be converted into shares from December 29, 2021, to June 22, 2027 [1] - The conversion price for the bonds is set at RMB 38.65 per share, and if the stock price falls below 70% of this price (RMB 27.06) for 30 consecutive trading days, the conditional redemption clause will take effect [1] - The company announced that the convertible bonds will be suspended from conversion starting August 8, 2025, for a period of 5 trading days due to the implementation of the redemption [2] Group 2 - The suspension of conversion will last until August 14, 2025, and will resume on August 15, 2025, after the redemption application period ends [2] - The company has ensured that the information disclosed is true, accurate, and complete, with no misleading statements or significant omissions [1]